Clinical Data Scientist -RWE Data Analysis Oversight Lead: Inflammation

Clinical Data Scientist - RWE Data Analysis Oversight Lead:
Inflammation Key Responsibilities

• Oversee timeliness and quality of analysis results supporting the CDS-RWE Inflammation therapeutic area portfolio.
• Track, prioritize, and manage execution of analysis deliverables across the TA portfolio.
• Partner on data strategy and advanced analytical tools/methods for the TA portfolio.
• Manage vendor performance; elevate risks impacting the TA portfolio.
• Own end-to-end oversight of deliverables (programming/analysis and outputs), including quality acceptance, risk identification, and mitigation.
• Monitor translation of observational research protocols/requirements into vendor analysis specifications and deliverables.
• Review quality of specifications, programs, cohorts, feasibility/results, publications/abstracts, and other outputs.
• Ensure locking/archiving as appropriate; coordinate analysis utilization and vendor assignment.
• Resolve vendor quality/scope/timeliness issues; maintain communication with vendors and service providers on priorities/milestones.
• Ensure vendor onboarding to analysis tools/programming environments and access to observational data.
• Identify/document efficiency improvements and collaborate with other TA oversight roles and the Gilead Data Office for training on licensed observational datasets.

• Bachelor’s + 12 years OR Master’s + 10 years OR PhD + 8 years.

• 5+ years generating observational research analysis deliverables.
• BS required; MS+ preferred in CS/Data Science/Biostatistics/Epidemiology.
• GxP compliant SAS/R experience with primary and real-world data.
• Experience leading programmers/data analysts in matrixed environments; strong written/verbal communication; RWE regulatory landscape and international data/OMOP preferred.

• Create Inclusion;
  Develop Talent;
  Empower Teams.

• Salary range varies by location; benefits may include medical, dental, vision, life, PTO, and eligibility for discretionary bonus/incentives.